With the market at all-time highs, Veeva has been a standout performer in the cloud software sector. On May 26, the stock price closed at $66.82 after the latest earnings results exceeded expectations. Clearly, 2017 has been a great year for Veeva (NYSE: VEEV). Is the tremendous growth susta
Athletic apparel stock Lululemon Athletica inc (NASDAQ: LULU)reported earnings for the first quarter ended April30, 2017along witha plan to restructure its ivivva operations. Net revenuerose 5% to$520.3 millionas total comparable sales decreased 1% whiledirect to consumer net revenue was fla
The biggest gold investing news of 2017 has been the price of gold’s huge rebound.
Since the first trading day of the year on Jan. 3, gold prices have gained 7.5% to $1,240. This rise follows a 9.8% decline during the last two months of 2016 that ended with gold bottoming at $1,132 on Dec. 15. Not only that, but the gold price’s 2017 climb so far outpaces both the S&P....More>>>
24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results in this shortened trading week. Thanksgiving is upon us and only a few companies are reporting this week, considering the markets are closed on Thursday and Black Friday is a day manytake off.
Keep in mind that the U.S. presidential election has ended and President-Elect Trump is now....More>>>
Late last week, our Under the Radar Moversnewsletter suggested going long on small cap clinical-stage biopharmaceutical Tetraphase Pharmaceuticals (NASDAQ: TTPH):
It’s been a stop-start effort since November’s low, but the turnaround effort from Tetraphase Pharmaceuticals has indeed taken hold. The former resistance line at $4.18 has now become a floor, and we’ve seen several....More>>>
In its first quarter report, Ciena posted a big profit beat, a solid revenue beat, and strong guidance, which was a relief for investors, considering some of the malaise that has been plaguing the optical communication sector of late. While Ciena stock jumped more than 15% on the day, the ri
Americans are investing in their looks more than ever before, and one of the things they're sinking their teeth and their money into is cosmetic dentistry. According to the American Academy of Cosmetic Dentistry (AACD), Americans are spending at least $2.75 billion annually on cosmetic dentistry
Amicus Therapeutics (NASDAQ:FOLD) reported additional positive data from its Pompe disease phase 1/2 study in May. I wrote about this candidate and its potential of becoming the new standard of care for Pompe disease earlier this year, based on its preclinical profile and early clinical data
While most of the world was consumed with former FBI Director James Comey's riveting Senate testimony last week, the GOP majority in the House of Representatives quietly prosecuted its war on retirement.
House Republicans under the leadership of Speaker Paul Ryan passed a "Financial CHOICE"